Does the DASH diet lower blood pressure by altering peripheral vascular function

Journal of Human Hypertension

Volumn 24, Issue 5, 2010, Pages 312-319

  Hodson, L ^a   Harnden, K E ^a   Roberts, R ^a   Dennis, A L ^a,b   Frayn, K N ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Apolipoprotein B; Blood pressure; DASH diet; Peripheral vascular function

Indexed keywords

APOLIPOPROTEIN B; C REACTIVE PROTEIN; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADIPOSE TISSUE BLOOD FLOW; ADULT; ARTERY DILATATION; ARTICLE; BLOOD VESSEL FUNCTION; BRACHIAL ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; FEMALE; GLUCOSE INTAKE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; MALE; PARASYMPATHETIC TONE; PATIENT COMPLIANCE; PERIPHERAL CIRCULATION; PROTEIN BLOOD LEVEL; PROTEIN INTAKE; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; WEIGHT CHANGE;

ADIPOSE TISSUE; ADULT; AGED; APOLIPOPROTEINS B; BLOOD PRESSURE; BRACHIAL ARTERY; C-REACTIVE PROTEIN; CHOLESTEROL, LDL; DIET; DIET, CARBOHYDRATE-RESTRICTED; DIET, FAT-RESTRICTED; ENDOTHELIUM, VASCULAR; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; REGIONAL BLOOD FLOW; VASCULAR RESISTANCE; VASODILATION;

EID: 77951095895     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2009.65     Document Type: Article

References (37)

1. Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996; 275: 1571-1576.
2. Himmelmann A, Hedner T, Hansson L, O'Donnell CJ, Levy D. Isolated systolic hypertension: an important cardiovascular risk factor. Blood Press 1998; 7: 197-207.
3. Lackland DT, Egan BM. The dominant role of systolic hypertension as a vascular risk factor: evidence from the southeastern United States. Am J Med Sci 1999; 318: 365-368.
4. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360: 1347-1360.
5. Staessen JA, Wang J-G, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001; 358: 1305-1315.
6. Collaboration BPLTT, Turnbull F, Neal B, Ninomiya T, Algert C, Arima H et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 2008; 336: 1121-1123.
7. Krousel-Wood MA, Muntner P, He J, Whelton PK. Primary prevention of essential hypertension. Med Clin North Am 2004; 88: 223-238.
8. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997; 336: 1117-1124.
9. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344: 3-10.
10. Conlin PR, Erlinger TP, Bohannon A, Miller 3rd ER, Appel LJ, Svetkey LP et al. The DASH diet enhances the blood pressure response to losartan in hypertensive patients. Am J Hypertens 2003; 16: 337-342.
11. Obarzanek E, Sacks FM, Vollmer WM, Bray GA, Miller 3rd ER, Lin P-H et al. Effects on blood lipids of a blood pressure-lowering diet: the dietary approaches to stop hypertension (DASH) trial. Am J Clin Nutr 2001; 74: 80-89. (Pubitemid 32574914)
12. Ard JD, Grambow SC, Liu D, Slentz CA, Kraus WE, Svetkey LP. The effect of the PREMIER interventions on insulin sensitivity. Diabetes Care 2004; 27: 340-347.
13. Harsha DW, Sacks FM, Obarzanek E, Svetkey LP, Lin PH, Bray GA et al. Effect of dietary sodium intake on blood lipids: results from the DASH-sodium trial. Hypertension 2004; 43: 393-398.
14. Lund-Johansen P. Newer thinking on the hemodynamics of hypertension. Curr Opin Cardiol 1994; 9: 505-511.
15. Vogel RA, Corretti MC, Plotnick GD. The postprandial effect of components of the Mediterranean diet on endothelial function. J Am Coll Cardiol 2000; 36: 1455-1460.
16. Azadbakht L, Kimiagar M, Mehrabi Y, Esmaillzadeh A, Hu FB, Willett WC. Soy consumption, markers of inflammation, and endothelial function: a cross-over study in postmenopausal women with the metabolic syndrome. Diabetes Care 2007; 30: 967-973. (Pubitemid 46556594)
17. Coppack SW, Evans RD, Fisher RM, Frayn KN, Gibbons GF, Humphreys SM et al. Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal. Metabolism 1992; 41: 264-272.
18. Summers LKM, Samra JS, Humphreys SM, Morris RJ, Frayn KN. Subcutaneous abdominal adipose tissue blood flow: variation within and between subjects and relationship to obesity. Clin Sci 1996; 91: 679-683.
19. Karpe F, Fielding BA, Ilic V, Macdonald IA, Summers LK, Frayn KN. Impaired postprandial adipose tissue blood flow response is related to aspects of insulin sensitivity. Diabetes 2002; 51: 2467-2473.
20. Jansson PA, Larsson A, Lonnroth PN. Relationship between blood pressure, metabolic variables and blood flow in obese subjects with or without non-insulindependent diabetes mellitus. Eur J Clin Invest 1998; 28: 813-818.
21. Ardilouze J, Fielding B, Currie J, Frayn K, Karpe F. Nitric oxide and beta-adrenergic stimulation are major regulators of pre- and postprandial subcutaneous adipose tissue blood flow in humans. Circulation 2004; 109: 47-52.
22. Tan GD, Neville MJ, Liverani E, Humphreys SM, Currie JM, Dennis AL et al. The in vivo effects of the Pro12Ala PPARg2 polymorphism on adipose tissue NEFA metabolism: the first use of the Oxford Biobank. Diabetologia 2006; 49: 158-168.
23. Schofield WN. Predicting basal metabolic rate, new standards and review of previous work. Hum Nutr: Clin Nutr 1985; 39C: 5-41.
24. Bland M. An Introduction to Medical Statistics, 2nd edn. Oxford University Press: Oxford, 1995.
25. Fung TT, Chiuve SE, McCullough ML, Rexrode KM, Logroscino G, Hu FB. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch Intern Med 2008; 168: 713-720.
26. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi T, Azizi F. Beneficial effects of a dietary approaches to stop hypertension eating plan on features of the metabolic syndrome. Diabetes Care 2005; 28: 2823-2831.
27. Bickerton AS, Roberts R, Fielding BA, Tornqvist H, Blaak EE, Wagenmakers AJ et al. Adipose tissue fatty acid metabolism in insulin-resistant men. Diabetologia 2008; 51: 1466-1474.
28. Wendelhag I, Fagerberg B, Hulthe J, Bokemark L, Wikstrand J. Endothelium-dependent flow-mediated vasodilatation, insulin resistance and the metabolic syndrome in 60-year-old men. J Intern Med 2002; 252: 305-313. (Pubitemid 35253698)
29. Lind L. Endothelium-dependent vasodilation, insulin resistance and the metabolic syndrome in an elderly cohort: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Atherosclerosis 2008; 196: 795-802.
30. Scuteri A, Tesauro M, Rizza S, Iantorno M, Federici M, Lauro D et al. Endothelial function and arterial stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndrome. Nutr Metab Cardiovasc Dis 2008; 18: 349-356.
31. Golledge J, Leicht AS, Crowther RG, Glanville S, Clancy P, Sangla KS et al. Determinants of endothelial function in a cohort of patients with peripheral artery disease. Cardiology 2008; 111: 51-56.
32. Galetta F, Franzoni F, Plantinga Y, Ghiadoni L, Rossi M, Prattichizzo F et al. Ambulatory blood pressure monitoring and endothelium-dependent vasodilation in the elderly athletes. Biomed Pharmacother 2006; 60: 443-447.
33. Lind L. Endothelium-dependent vasodilation in relation to different measurements of blood pressure in the elderly: the prospective investigation of the Vasculature in Uppsala Seniors study. Blood Press Monit 2008; 13: 245-250.
34. Fuentes F, López-Miranda J, Sánchez E, Sanchez F, Paez J, Paz-Rojas E et al. Mediterranean and low-fat diets improve endothelial function in hypercholesterolemic men. Ann Intern Med 2001; 134: 1115-1119.
35. Lafortuna CL, Adorni F, Agosti F, Sartorio A. Factor analysis of metabolic syndrome components in obese women. Nutr Metab Cardiovasc Dis 2008; 18: 233-241.
36. Berrahmoune H, Herbeth B, Samara A, Marteau J-B, Siest G, Visvikis-Siest S. Five-year alterations in BMI are associated with clustering of changes in cardiovascular risk factors in a gender-dependant way: the Stanislas study. Int J Obes 2008; 32: 1279-1288.
37. Scheen AJ, Finer N, Hollander P, Jensen MD, Van Gaal LF. Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. Lancet 2006; 368: 1660-1672.